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Human pluripotent stem cells (hPSCs) are increasingly used for cell-based regenerative
therapies worldwide, with embryonic and induced pluripotent stem cells as potential
treatments for debilitating and chronic conditions, such as age-related macular
degeneration, Parkinson’s disease, spinal cord injuries, and type 1 diabetes. However,
with the level of genomic anomalies stem cells generate in culture, their safety may be
in question. Specifically, hPSCs frequently acquire chromosomal abnormalities, often
with gains or losses of whole chromosomes. This review discusses how important it
is to efficiently and sensitively detect hPSC aneuploidies, to understand how these
aneuploidies arise, consider the consequences for the cell, and indeed the individual
to whom aneuploid cells may be administered.
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INTRODUCTION
Stem cells are unspecialized cells that can give rise to a ranged of different cell types through self-
renewal. Adult (mesenchymal) stem cells (MSCs) can be found throughout the body in various
niches, such as the small intestine, colon or bone marrow (Barker et al., 2007; Hérault et al., 2017).
Embryonic stem cells (ESCs) on the other hand are derived from the inner cell mass of an early
preimplantation embryo or blastocyst and can differentiate to form all three germ cell layers. Such
cells are known as pluripotent cells, since they give rise to every cell type of the body, excluding the
extra-embryonic membrane and placental tissue. With such immense therapeutic potential, stem
cells could be used for tissue repair and potentially replacement of whole organs through tissue
engineering, circumventing the problem of a current lack of organ donors (Badylak et al., 2011).
Due to their pluripotent properties, the treatment of many diseases such as age-related macular
degeneration (Song et al., 2015), spinal cord injuries (Deshpande et al., 2006), type 1 diabetes
(Farooq et al., 2018), and Parkinson’s disease (Bjorklund et al., 2002; Takagi et al., 2005; Grealish
et al., 2014; Barker et al., 2016) may soon become a reality.
Induced pluripotent stem cells (iPSCs) are pluripotent cells generated by the reprogramming
of differentiated cells and can likewise give rise to a range of different cell types. iPSCs may be
considered as the ideal therapeutic resource since an autologous stem cell transplant negates the
need for human leukocyte antigen (HLA) matching and any immunosuppression required with
allogenic transplants, as well as providing an endless supply of personalized therapeutic product if
21 January 2019
Henry et al. Genomic Health of Stem Cells
required. It has been estimated that a relatively small number of
iPSC lines need be generated to meet a demand that covers most
of the world’s population via the generation of HLA matched
banks, making it both cost-effective and simpler for thorough
characterization from a regulatory perspective (Taylor et al.,
2012; Turner et al., 2013; Solomon et al., 2015). iPSCs are
created from differentiated cells and can be reprogrammed to
become pluripotent mainly through three genes: OCT4, SOX2,
and NANOG, which induce and maintain the upregulation of
pluripotency genes whilst repressing lineage-associated genes.
Both ESCs and iPSCs are noted for their accumulation of
chromosomal aneuploidies, especially after prolonged in vitro
culturing (Amps et al., 2011). Similarly, cells of the blastocyst
also exhibit a high rate of mitotic aneuploidy (Taylor et al., 2014)
and thus it is possible that the chromosomes of pluripotent cells
are inherently unstable. Interestingly, in the blastocyst, more
chromosome losses than gains are observed (Chung et al., 2013;
Yao et al., 2016), in contrast to hESCs having more gains, which
may lead to these affected hESCs having a greater selective
advantage in cell culture (Amps et al., 2011). Typically hESC
chromosome aneuploidies include chromosomes 1, 12, 17, 20,
and X (Draper et al., 2004; Maitra et al., 2005; Baker et al., 2007)
(Figure 1). This is in contrast to live births, where the most
common aneuploidies are for chromosomes containing fewer
genes i.e., autosomes 13, 18, and 21 (Caine et al., 2005) along
with the sex chromosomes (Munné et al., 1998), and spontaneous
abortions, where common aneuploidies include chromosomes 4,
7, 13, 15, 16, 21, and 22 (Fritz et al., 2001) (Table 1). Seemingly the
aneuploidies accumulating in the hPSC culture are incompatible
with life and are strikingly similar to the aneuploidies found in
human embryonal carcinoma cells (hECCs), with respect to the
types of karyotypic changes observed (Summersgill et al., 2001;
Reuter, 2005; Harrison et al., 2007) and in their gene expression
profiles (Sperger et al., 2003), suggesting a tumorigenic potential.
Furthermore, stem cells with these recurrent gains or losses
display a growth advantage in culture (Amps et al., 2011; Avery
et al., 2013; Peterson and Loring, 2014), signifying that these
chromosomes contain critical genes needed for cell growth,
pluripotency and possibly tumorigenesis. This poses a serious
threat to the therapeutic use of hPSCs, as the effects of using
genomically abnormal or unstable stem cells in patients is
unknown (Brimble et al., 2004; Draper et al., 2004; Peterson and
Loring, 2014). Those chromosomal rearrangements common to
hESCs and hECCs are candidates as drivers of tumorigenesis.
Gene sequence and copy-number mutations affecting known
oncogenes may also drive tumorigenesis. Screening oncogenes
for mutations in hESCs might therefore become a necessity
in providing a risk analysis of hESC lines prior to use in cell
therapies. Indeed, in a study of 140 hESC lines, 5 were found to
contain mutations in the oncogene TP53 (Merkle et al., 2017),
highlighting the risk of employing hPSCs for cellular therapies.
What effect(s) the hPSC aneuploidies may have, if cells
containing them are administered to patients, needs to be
addressed. An issue that is particularly important to address is
the risk of transplanting hPSCs into individuals without being
able to control their self-renewal capacity (Kanemura et al.,
2014). The possibility of a malignant transformation of the cells
followed by unregulated proliferation could limit stem cells use
for future therapies (Blum and Benvenisty, 2008; Herberts et al.,
2011; Ben-David et al., 2014). Worryingly, it has already been
demonstrated that the transplantation of aneuploid cultured
murine MSCs leads to malignant transformation in vivo (Miura
et al., 2006). This could lead to devastating consequences if
patients were recipients of genomically unstable hPSCs. Tumor
development from non-host origin has been reported after the
injection of karyotypically normal neural stem cells into an
Ataxia Telangiectasia patient (Amariglio et al., 2009). Whilst
many details of the procedure were not disclosed, it is thought
that sufficient genomic characterization of the donor cells was
not performed prior to transplantation (Baker, 2009). This case,
along with the supporting studies presenting mosaicism (Amps
et al., 2011; Merkle et al., 2017) and recurrent chromosomal
abnormalities (Brimble et al., 2004; Draper et al., 2004; Baker
et al., 2007; Amps et al., 2011) giving rise to growth advantage
in culture, highlights the importance of vigorous characterization
of the hPSCs before transplantation if such cells were to be used
regularly in therapies, and also the need for the development of
novel analytics for such characterization.
Additionally, it has been reported that somatic cells with pre-
existing chromosomal mutations limited the reprogramming of
the cells to iPSCs (Yang C. et al., 2008). However, recent in vitro
studies, generating hESCs with trisomies of either chromosomes
6, 8, 11, 12, or 15, demonstrate that proliferation may not be the
issue, but the ability of stem cells containing aneuploidies to be
able to differentiate efficiently and in a timely fashion is (Zhang
et al., 2016). These experimentally induced aneuploidies also
gave rise to global changes in gene expression profiles, evident
in the differentiated somatic cells whereby gene expression
alterations were found throughout the genome (Dürrbaum and
Storchová, 2016). These technical issues once again demonstrate
the inefficiency and potential malignancy of using aneuploid
hPSCs in therapies.
It is concerning that aneuploid hPSCs may have a growth
advantage in vivo, due to the selection of specific gene gains or
losses, driving the concomitant gain or loss of part or whole
chromosomes e.g., the gain of chromosome 20 in hPSCs driven
by the BCL2L1 gene (Enver et al., 2005; Baker et al., 2007). This
gene is associated with anti-apoptotic properties (Boise et al.,
1993; Amps et al., 2011; Avery et al., 2013; Na et al., 2014) and
is a hallmark of cancer (Herszfeld et al., 2006; Yang S. et al.,
2008; Avery et al., 2013). Knock-down of BCL2L1 diminished
the growth advantage effect and thus, this gene is likely to be
the driver of chromosome 20 accumulation in hESC cultures
(Avery et al., 2013). Following the event that creates aneuploid
cells, selection is then required to increase the proportion of
aneuploid cells relative to the normal diploid cell population.
There are several points during hESC culture at which selection
could operate, but evidence points to the mechanism used for
disaggregating cells for passaging. For example, aneuploidies
were gained when employing enzymatic and non-enzymatic
methods of cell dissociation, rather thanmanual colony cutting in
hESC cultures (Mitalipova et al., 2005). Furthermore, aneuploid
cells showed an increase in the expression of pluripotency
genes and early differentiation genes, implying that the cell
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FIGURE 1 | Aneuploid Gene Loci within Human Embryonic Stem Cells. Aneuploid pluripotent stem cell nuclei subjected to fluorescence in-situ hybridization
displaying AMELX gene loci in green and nuclear DNA stained with DAPI in blue. Scale bar is 10µm.
disaggregation method may induce widespread changes in the
phenotype of the cell culture. Candidate genes suggested to
infer a growth advantage include the pluripotency–related genes
NANOG, DPPA3, and GDF3, oncogene KRAS, and cell cycle
regulator CCND2 on chromosome 12, and BIRC5 (SURVIVIN)
on chromosome 17 (Na et al., 2014). It is also possible that
mutation-bearing cells with no selective advance in culture
may become present at significant levels to chance-effects in
the bottleneck created by colony-cutting and poor cell survival
rates upon passage. However, with the limitations of current
analytics, it is difficult to discern the precise levels of aneuploidies
appearing in culture.
In this article, we will review the mechanisms by which
aneuploidies may arise in hPSCs, and the potential impact on
genome organization and stability, concluding with an analysis
on the current tools available to measure genomic aberrations
toward ensuring safe therapeutic application.
HOW ANEUPLOIDIES ARISE
In order to maintain genomic integrity, it is essential that
with each cell division the distribution of chromosomes in
each daughter cell is matched. Unfortunately, how exactly
aneuploidies arise in human pluripotent stem cells is not yet
entirely known. We discuss here a number of mechanisms that
could lead to the formation of aneuploidies and discuss the
genomic abnormalities that may contribute to aneuploidy status.
Mitotic Segregation Defects
Telomeres are repetitive nucleotide sequences found at the end
of chromosomes to prevent chromosome end-to-end fusions,
which can result in chromosome instability. Normally, telomeres
shorten as a result of each cell division, although in stem cells
telomerase is active to ensure the maintenance of telomere length
(Greider and Blackburn, 1989; Feng et al., 1995; Nakamura and
Cech, 1998). In hESCs, the telomerase enzyme is continually
active in order to maintain the extended length of telomeres
and in iPSCs, telomerase is re-activated after reprogramming
and the process of telomere lengthening begins (Takahashi and
Yamanaka, 2006; Takahashi et al., 2007; Marión et al., 2009).
When two end-to-end fused chromosomes are being pulled
apart by opposing mitotic spindle tubules, anaphase bridges or
chromatin bridges can occur which create a link between the
two daughter cells. Although the formation of anaphase bridges
does occur in normal cells (Baumann et al., 2007; Chan et al.,
2007), it is strongly associated with the erosion of telomeres
(Tusell et al., 2010). The inability of the fused chromosomes
to part leads to one daughter cell gaining a chromosome and
the other losing a chromosome. Further, end-to-end fusion of
chromosomes can cause breakage-fusion-bridge (BRB) cycles to
be established, resulting in genomic instability (DePinho, 2000;
Gisselsson et al., 2001; Hackett et al., 2001) and in turn causing
the shearing of ultra-fine bridges also generating aneuploidy.
Telomeric sequences are associated with a group of proteins;
TRF1, TRF2, RAP1, POT1, TIN1, and TIN2, collectively known
as the shelterin complex (Liu et al., 2004). Disruption of these
proteins can cause fragile sites in the genome, contributing to
DNA replication defects (Sfeir et al., 2009), anaphase bridges
(Bunch et al., 2005; Nera et al., 2015), chromosome fusions
(Pardo and Marcand, 2005) and the activation of DNA damage
responses (Palm and de Lange, 2008). A recent study has revealed
that overexpression of the telomere repeat-binding factor 1
(TRF1) in mouse ESCs can indeed cause anaphase bridges to
form (Lisaingo et al., 2014), thus indicating the importance of
telomere protection in hESCs. Most interestingly, in ESCs with
short telomeres (Huang et al., 2011) and in the full knockout
of a subunit of telomerase, Tert -/- ESCs (Pucci et al., 2013),
reduced levels of pluripotency have been observed. Indeed, long
telomeres and high TRF1 levels have been proposed as additional
stem cell markers (Flores et al., 2008; Huang et al., 2011;
Schneider et al., 2013). However, although the overexpression of
telomerase did improve the self-renewal and proliferation rate, it
increased resistance to apoptosis and caused a suppression in the
differentiation capacity of ESCs (Armstrong et al., 2005; Yang C.
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TABLE 1 | Chromosomal abnormalities in specific cell types or in live births and
spontaneous abortions.
Cell type Chromosomal abnormalities
Embryonic stem cells 1, 12, 17, 20, X
Induced pluripotent stem cells 1, 9, 12, 20, X
Human embryonal carcinoma cells 1, 12, 17, 20, X
Live births 13, 18, 21, X, Y
Spontaneous abortions 4, 7, 13, 15, 16, 21, 22
Specific chromosome gains and/or losses that occur most commonly in the different cell
types, and in live births and spontaneous abortions.
et al., 2008). These findings suggest a potential range for optimal
telomere length in the hPSCs, which could be used as a screening
method, in the cells intended for clinical use.
On occasion, the sister chromatids are not resolved correctly
during mitosis, due to the lack of kinetochore attachment
to the mitotic spindle, with one daughter cell receiving both
chromosomes, and an aneuploid status in both cells. How the
mitotic spindles assemble in hPSCs is not well investigated,
however, spindle defects such as asymmetric orientation have
been linked with carcinogenesis in Drosophila melanogaster
(Caussinus and Gonzalez, 2005; Castellanos et al., 2008) and in
human gut epithelial stem cells (Quyn et al., 2010). A balance of
symmetric or asymmetric cell divisions are necessary for normal
development and tissue homeostasis, however this can lead to
abnormal proliferation (Noatynska et al., 2012). Alternatively,
lagging chromosomes derived from mitotic spindle detachment
or the bipolar orientation of chromatids (Cimini et al., 2002)
can instead form a separate compartment of chromatin away
from nuclei. Atelometric and acentric, whole or fragmented
chromosomes, can become micronuclei (Cimini et al., 1999;
Minissi et al., 1999; Norppa and Falck, 2003) or double-minute
(DM) chromatin, where small fragments of amplified genes occur
extra-chromosomally (Haaf and Schmid, 1988; Itoh and Shimizu,
1998). Although nuclear contentsmay be lost in thismanner, they
can also be engulfed into nuclei (Minissi et al., 1999). Micronuclei
or DMs can appear as a result of replicative stress and sometimes
still remain transcriptionally active, albeit at reduced levels
(Hoffelder et al., 2004; Utani et al., 2007). These micronuclei
can also contain nucleoskeletal structural components such as
nuclear lamins and thus are not totally inert (Tanaka and
Shimizu, 2000). Both pluripotent and differentiating ESCs seem
to have a propensity to form micronuclei: in mouse ESCs, an
increase in micronuclei formation and apoptosis was observed
with the downregulation of the pluripotencymarkerOCT4 (Zhao
et al., 2014), additionally differentiation of murine ESCs to neural
progenitor cells causes a nearly 2-fold increase in micronuclei
formation and an increase in chromosome instability (Sartore
et al., 2011). Indeed, the high rate of proliferation of hESCs in
itself could promote the formation of micronuclei and thus be
a factor contributing to their genomic instability (Stopper et al.,
2003).
The apoptosis inhibitor protein, survivin, normally protects
against polyploidy through its function in the control of
the spindle assembly checkpoint and cytokinesis. Impairment
of survivin expression has been associated with polyploidy
development in human cells (Li et al., 1999). Survivin is highly
expressed in ESCs (Adida et al., 1998) and has been shown to
be fundamental in maintaining pluripotency (Mull et al., 2014;
Kapinas et al., 2015) by being involved, with its splice variants, in
the upregulation of NANOG and OCT4 (Mull et al., 2014). Thus,
there is a case for survivin expression to be tested for as part of a
genomic health screen for clinical-grade stem cells.
DNA Damage
During development, blastocyst cells may have to compromise
their DNA proof-reading capability in order to achieve a rapid
rate of cell division. This postulation is supported by the
shortened G1 phase of interphase in ESCs in culture (Becker
et al., 2006; Ghule et al., 2008), exposing them to potentially
higher replicative errors. Furthermore, studies of the TP53-p21
pathways in hESCs have revealed that during stress stimuli, the
p21 mRNA is upregulated in hESCs, however no p21 protein
is detected (Dolezalova et al., 2012). This could imply that
although the cell has responded to stress, it has not been
able to achieve p21 function, allowing replication errors to
remain. During DNA damage in hESCs, TP53 binds directly
to NANOG’s promoter, suppressing it and promoting hESC
differentiation (Lin et al., 2005). If p53 levels are reduced, the
levels of spontaneous differentiation are also reduced (Kawamura
et al., 2009). It seems that in hiPSCs, DNA damage does not
give rise to single-stranded DNA regions, checkpoints are not
activated, and thus DNA repair does not occur (Desmarais
et al., 2012), despite there being elevated expression levels of
DNA repair genes (Momcilovic et al., 2010). This is echoed
in studies of mouse cells, whereby iPSCs were less able to
perform double-strand break repair, especially by homologous
recombination repair, compared with both primary cells and
ESCs (Zhang et al., 2018). Furthermore, hiPSCs have been
found to be deficient in intra-S checkpoints and also in G2/M
decatenation or chromatin dis-entanglement, preventing delayed
entry of inappropriately condensed chromosomes into mitosis
and permitting the formation of anaphase bridges (Damelin et al.,
2005; Filion et al., 2009;Weissbein et al., 2014; Lamm et al., 2016).
Topoisomerase II permits chromatin decatenation to occur in G2
to delay mitosis and allow smooth sister chromatid segregation
(Uemura et al., 1987; Holm et al., 1989). When the decatenation
checkpoint is disrupted, entangled chromosomes segregate and
then form new cells with aneuploidy (Gorbsky, 1994; Andoh
and Ishida, 1998). Chromosome decatenation deficiency has
also been reported in mouse ESCs and human multipotent
progenitor cells, however improved decatenation was observed
later with cell differentiation (Damelin et al., 2005). The reason
behind such entanglement of ESC chromatin may be due to the
lack of higher chromatin organization in the nucleus, such as
heterochromatin. hESC nuclei lack chromatin silencing markers,
such as methylation on H3K9 and H3K27. The plasticity of the
chromatin, causes the DNA to be a highly open structure and
coupled with the dispersed presence of the DNA damage marker,
γ-H2AX in hESCs (Meshorer et al., 2006), in stark comparison to
more localized foci in somatic cells (Mariotti et al., 2013), suggests
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a more exposed, and therefore a more easily damaged chromatin.
The plasticity of the more-open chromatin state in stem cells
could be one of the reasons for the increased genomic instability
of hPSCs when cultured in vitro. Increased levels of γ-H2AX
were also noted in hiPSCs compared with their source primary
line (Vallabhaneni et al., 2018), suggesting a similar scenario in
these cells. Although, this may be debatable since no additional
protection of heterochromatin, in comparison to euchromatin,
has been observed from the reactive oxygen species (ROS)-
induction of double-stranded breaks (Woodbine et al., 2011).
But, lower levels of Ataxia-telangiectasia mutated kinase (ATM)
phosphorylation in iPSCs has been previously reported in cells
treated with low levels of radiation, alongside hypersensitivity to
apoptosis (Nagaria et al., 2016). ATM phosphorylates a number
of proteins, related to apoptosis, cell cycle checkpoints, and DNA
repair (Lee and Paull, 2007), therefore its potentially reduced
role in hPSCs should be carefully considered. The exact role of
ATM in DNA damage in heterochromatin is still unknown, but
it has been suggested to be preferentially required in the DNA
damage repair of heterochromatin (Goodarzi et al., 2008). As
hPSCs lack the presence of heterochromatin (Francastel et al.,
2000; Meshorer and Misteli, 2006), the reduced levels of ATM
phosphorylation (Nagaria et al., 2016) probably would not have
a significant effect on the genomic integrity of the cell. However,
ATM-deficient cells were less efficient in reprogramming to iPSC,
which influenced the appearance of genomic variation (Marión
et al., 2009; Kinoshita et al., 2011; Lu et al., 2016). Similarly,
Artemis, an endonuclease associated with non-homologous end-
joining, is required for the maintenance of genomic stability
(Woodbine et al., 2011), but its absence from stem cells did
not impair myeloid differentiation, reprogramming or show any
signs of significant genomic instability (Felgentreff et al., 2014).
Despite the susceptibility of hPSCs to DNA damage in vitro,
steps may be taken to alleviate this by the modification of
culture conditions, including freeze-thaw techniques, passaging
(Mitalipova et al., 2005), and media composition: a reduction
in MEK inhibition (involved in the regulation of DNA
damage/repair and cell cycle) was observed to maintain naive
hESCs, accelerate proliferation, and reduce the accumulation of
chromosomal abnormalities in culture (Di Stefano et al., 2018).
Bystander Effect?
Another putative mechanism for the process of aneuploidy
accumulation is that cells acquire an aneuploidy and then via a
bystander effect further aneuploidies accumulate in neighboring
cells. Such mechanisms have been observed with radiation-
treated cells causing cell senescence in neighboring cells (Nelson
et al., 2012), increased sister chromatid exchange (Nagasawa and
Little, 1992; Deshpande et al., 1996), increased TP53 expression
(Hickman et al., 1994; Azzam et al., 1998), and most importantly
chromosomal instability (Lorimore et al., 1998; Sawant et al.,
2001). This instability in the irradiated cells is probably observed
due to the ROS produced from the radiation (Yamamori et al.,
2012) causing DNA damage to occur (Yermilov et al., 1996;
Balasubramanian et al., 1998). Most interestingly, a bacterium
species has been shown to induce aneuploidy, amongst other
hallmarks of genomic instability, in human cells, through a
bystander effect. Enterococcus faecalis, an intestinal bacterium,
where the production of ROS molecules induced chromosome
instability in cells with defects in mismatch repair genes (Huycke
et al., 2001, 2002; Wang et al., 2008). Although this theory
needs to be investigated further, it is well established that
ROS and nitrogen species from both radiation and metabolism
can cause oxidative stress that can lead to DNA damage and
senescence in cells (Lindahl, 1993; Suh et al., 1999; Geiszt
et al., 2000). Moreover, it may be the case with hPSCs that if
one event triggers an aneuploidy to occur, a bystander effect
could then cause neighboring cells to also acquire aneuploidies,
through transmission of substances through the culture media or
delivered in exosomes. For example, if mitomycin C, a commonly
used growth inhibitor of feeder cells, were to negatively affect
the hPSC basement membrane, then we theorize that this might
affect the neighboring stem cells. This event can then cause or
promote the generation of further aneuploidies in the hPSC
culture. Asmore hESC lines are developed on, or adapted to other
alternative matrices, it should become more apparent if there are
any effects and whether it is the stem cells or the feeder cells that
potentially instigate aneuploidy.
It has been previously proposed that the increased age of cells
and the amount of ROS are linked (Finkel and Holbrook, 2000).
As human pluripotent stem cells are metabolically very active
and can be maintained in cultures for long periods of time, the
increased age and the fast metabolism required in these cells
could also be an aspect that factors in the genomic instability
often observed. In contrast, it has been reported that both high
and low levels of ROS can impair the reprogramming ability of
cells into iPSCs (Zhou et al., 2016) and elevated levels can impair
their differentiation ability as well (Rönn et al., 2017). These
studies suggest that optimal levels of ROSmay be required for the
cells to grow stably in culture. With the effect of ROS established
above, very precise growth conditions must be maintained in the
hPSC culture to ensure genomic integrity. We hypothesize that
the use of reagents, such as mitomycin C, could potentially affect
the neighboring hPSCs and should be carefully considered before
the assumption of no effect.
Nuclear Lamin Depletion
Lamins are a meshwork of proteins found at the nuclear
periphery with intimate associations with the inner nuclear
membrane and co-located proteins (Gruenbaum et al., 2000;
Zastrow et al., 2004). Nuclear lamins, which play an important
role in the maintenance of nuclear morphology and chromosome
organization (Aebi et al., 1986; Bridger et al., 2007; Dechat et al.,
2008; Bickmore and van Steensel, 2013), have also been suggested
to be involved in many other processes within the nucleus, such
as DNA replication and repair, transcription and RNA processing
(Cai, 2001; Laguri et al., 2001; Wolff et al., 2001; Spann et al.,
2002).
In humans, A-type lamins, such as lamin A and C, are encoded
by LMNA, whereas B-type lamins, such as lamins B1 and B2 are
encoded by LMNB1 and LMNB2, respectively (Wydner et al.,
1996). Unlike A-type lamins, lamins B1 and B2 are endogenously
expressed in both somatic and embryonic cells (Höger et al., 1990;
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Pollard et al., 1990; Lin and Worman, 1995). The presence of A-
type lamins in embryonic cells is still debated, as some reports
show that A-type lamins are expressed only in somatic cells
(Lehner et al., 1987; Stewart and Burke, 1987; Höger et al., 1990;
Hutchison, 2002), and are completely absent from the nuclei
in both ESCs (Constantinescu et al., 2006) and iPSCs (Mattout
et al., 2011), whereas more recent reports suggest that A-type
lamins are expressed at low levels in ESCs (Kim et al., 2011;
Eckersley-Maslin et al., 2013). In early embryos, A-type lamins
can be observed (Foster et al., 2005), but these are thought to be
gamete-derived and soon disappear.
A-type lamins are found to accumulate with the down-
regulation of OCT4, a hallmark of cell differentiation, and
this is thought to contribute to the ESC nuclear plasticity
(Constantinescu et al., 2006; Meshorer et al., 2006; Pajerowski
et al., 2007). Lamin A then associates with and anchors,
forming heterochromatin at the nuclear periphery, helping to
organize the genome, regulating it for lineage commitment
(Solovei et al., 2013); the accumulation of A-type lamins during
differentiation have been associated with the loss of nuclear
plasticity (Constantinescu et al., 2006; Meshorer et al., 2006;
Pajerowski et al., 2007). Mutations in the A-type lamins give rise
to a family of diseases commonly referred to as laminopathies,
often associated with tissues derived from the mesenchyme, such
as skeletal muscle, skin, cardiac muscle, tendons, adipose, and
neurons (Worman and Bonne, 2007). Indeed, LMNA mutations
cause impaired differentiation of adult mesenchymal stem cells
(Gotzmann and Foisner, 2006; Pekovic and Hutchison, 2008;
Scaffidi andMisteli, 2008), alterations inNotch andWnt signaling
pathways required for early development (Espada et al., 2008;
Meshorer and Gruenbaum, 2008; Scaffidi and Misteli, 2008;
Hernandez et al., 2010) and MSC death (Halaschek-Wiener
and Brooks-Wilson, 2007; Meshorer and Gruenbaum, 2008;
Prokocimer et al., 2009). Additionally, lamin A knockdown
affects the serum response factor (SRF) pathway that promotes
expression of abundant actin-myosin cytoskeletal components
involved in the differentiation of cells (Swift and Discher, 2014).
The SRF pathway is partially regulated by nuclear actin (Olson
and Nordheim, 2010; Baarlink et al., 2013), which binds to lamin
A (Simon et al., 2010) and other proteins associated with lamin A,
such as emerin (Simon and Wilson, 2011). In contrast, Lamin B1
and B2 knockout does not affect the differentiation of blastocysts,
but does affect organogenesis in mice (Coffinier et al., 2010;
Kim et al., 2011), as well as mitotic spindle orientation and
formation (Tsai et al., 2006; Ma et al., 2009; Kim et al., 2011). This
suggests that B-type lamins have a functional role in ensuring
chromosomes are efficiently segregated during mitosis. This
correlates with findings of lamin B2 depletion being associated
with aneuploidy formation, prolonged mitosis and formation of
anaphase bridges in cancerous cells (Kuga et al., 2014; Ranade
et al., 2017). Additionally, the depletion of lamin B2 caused the
mislocalization of chromosome territories (CTs) in aneuploid
cells (Ranade et al., 2017). In contrast, in mouse ESCs the knock-
out of B-type lamins and the mutation of Lmna did not cause
any effect on the proliferation and differentiation of mouse ESCs,
nor did it change the total number of chromosomes in nuclei
(Kim et al., 2013). It has been suggested that lamin B2, alongside
the inner nuclear membrane protein SUN1 (Malone et al., 2003;
Razafsky and Hodzic, 2009), supports the spindle pole during
mitotic spindle formation (Kuga et al., 2014). Indeed, SUN1
is required for telomere binding to the nuclear envelope and
disruption of SUN1 affects meiotic division (Ding et al., 2007).
We hypothesize that nuclear proteins, especially lamins, have
a key role in the maintenance of genomic stability of hPSCs.
Further work is required to establish whether B-type lamin loss
causes aneuploidies or aneuploidies induce the loss of B-type
lamins.
Chromosome Integrity Checkpoints
With all the scenarios that can go wrong in a cell with
respect to genomic instability, chromosome integrity and DNA
damage it is important that cells have adequate and well-
functioning checkpoints, to assess the health of the genome
(Sperka et al., 2012). For correct chromosome segregation there
are two critical checkpoints, known as the spindle assembly
checkpoint and the decatenation checkpoint. The G1 tetraploidy
checkpoint also assesses for chromosome aberration, especially
additional chromosomes (Brown and Geiger, 2018). Very
interestingly in murine ESCs the spindle assembly checkpoint
was not activated as it would be in somatic cells, leading to
apoptosis and so the possibility of a higher numbers of cells
with aneuploidy (Rohrabaugh et al., 2008). Furthermore, the
decatenation checkpoint which verifies for entanglement of
chromosomes that can happen with inadequate DNA damage
repair, has been revealed to not be activated in murine ESCs,
although it is activated once cells have committed to a lineage
(Damelin et al., 2005; Suvorova et al., 2016). Thus, the lack
of checkpoint function in embryonic stem cells is perhaps
a process to maintain stemness and openness of chromatin,
allowing aneuploidy and instability to arise in a population
but which can be overcome later, removing individual cells
that are too compromised. A further checkpoint that monitors
the numbers of centrosomes, a building block of the spindle
pole bodies has not yet been studied in stem cells; such
a screening test to assess centrosome number by antibody
staining probably should be included in a panel of assessments
and parameters to be tested prior to stem cell use in the
clinic.
Cyclin D1 levels are low in ESCs as compared to somatic
differentiated cells. Cyclin D1 is a pivotal component of the
G1/S transition in interphase. Interestingly, it is the presence
of specific microRNAs regulated by OCT4 and SOX2 that
prevent the expression of cyclin D1 (Card et al., 2008). For
iPSCs, reprogramming back to a less controlled cell cycle,
with “looser” checkpoints and shorter G1 and G2 phases is
thwarted by cyclin D1 (Chen et al., 2014). Figure 2 gives an
overview of the causes discussed that may permit aneuploidy to
arise.
Genome Organization Is Different in Stem
Cells
Earlier studies have analyzed the genome in somatic and indeed
stem cells with specific chromosome probes in fluorescence
in situ hybridization (FISH) visualized by high resolution
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FIGURE 2 | Possible causes of aneuploidy in pluripotent cells. This figure displays a cartoon of a mitotic cells outlining the possible causes of aneuploidy. A is the
normal situation where the centromere attaches to the microtubules of the spindle and a normal segregation occurs. B highlights a failure of segregation where the
chromosomes do not divide and an extra copy of a chromosome will be in one daughter nucleus and missing in the other. C is the situation where DNA damage is not
repaired properly and leads to entangled chromosomes that cannot segregate correctly, again giving an additional chromosome in one daughter nucleus and a lack of
that chromosome in the other. D represents the situation where issues with the complement of B-type lamins, specifically B2, leads to spindle assembly failure and so
chromosomes are lost or non-segregated chromosomes can become encompassed into one of the reforming daughter nuclei.
microscopy (Clements et al., 2016). The genome is highly
organized in somatic, differentiated cells (Bridger and Bickmore,
1998; Parada and Misteli, 2002; Tanabe et al., 2002; Foster et al.,
2012), with interphase chromosomes organized into individual
territories (Cremer and Cremer, 2001), called chromosome
territories in similar nuclear locations between different cell
types, with a few specific tissue related differences (Kuroda
et al., 2004; Parada et al., 2004; Foster et al., 2012; Robson
et al., 2016). On the whole, in proliferating cells a gene-density
distribution is observed with gene-rich chromosomes found
toward to the nuclear interior and gene-poor toward the nuclear
periphery (Bridger et al., 2014). A re-positioning occurs when
cells leave the proliferative cell cycle to quiescence or senescence
(Bridger et al., 2000; Mehta et al., 2010; Criscione et al., 2016).
Here, we review how chromosomes are arranged in hPSCs
compared with somatic cells and discuss whether the type of
strict genome organization and chromosome positioning found
in differentiated cells is pertinent and relevant to stem cells.
A gene-density radial distribution of CTs has been observed
in hESCs (Wiblin et al., 2005; Bártová et al., 2008), as it has been
in human somatic cells (Croft et al., 1999; Boyle et al., 2001)
and in human blastomeres (Finch et al., 2008). These data were
corroborated for stem cells by studies in pig cells whereby there
was very little difference in chromosome positioning between
mesenchymal stem cells from bone marrow and cells within
differentiated tissues (Foster et al., 2012). However, gene-rich
human chromosomes 17 and 19 were positioned more centrally
in granulocytes when compared to hESC (Bártová et al., 2001),
even though chromosome 12 and its centromere positioning in
pluripotent and somatic cells were reportedly the same (Bártová
et al., 2008). These data indicate that CT positioning in ESCs is
not as it will be once the cells have differentiated. This would
suggest that embryonic nuclei have mechanisms in place to
re-position interphase chromosomes. Further, in cloned bovine
embryos, CTs also do not relocate upon development but the
pluripotency genes are relocated to more transcriptionally active
regions of the territories (Orsztynowicz et al., 2017). Genes
looping away from CTs has been reported previously to be
associated with dependent transcription in specific cell types
(Volpi et al., 2000; Mahy et al., 2002). Indeed, the 12p region
that contains a group of clustered pluripotency genes, including
NANOG, was found to be located more centrally in hESCs than
in somatic cells (Wiblin et al., 2005). In contrast, chromosome
6p, containing the pluripotency marker OCT4, did not show any
difference in its nuclear position, whilst the OCT4 locus was
reported to move to outside its CT in ESCs (Wiblin et al., 2005).
Reports of a less rigid chromatin state, due in part to
the lack and/or absence of chromatin remodeling markers, in
undifferentiated cells has been reported (Keohane et al., 1996;
Francastel et al., 2000; Lee et al., 2004; Meshorer et al., 2006).
In normal somatic cells, centromeres are mostly found nearer
to the nuclear periphery or around nucleoli, and also often by
the CT periphery (Weierich et al., 2003; Gilchrist et al., 2004),
although this may depend on the stage of the cell cycle (Ferguson
et al., 1992; Weimer et al., 1992; Hulspas et al., 1994). Previous
reports have found that in human cells during differentiation,
centromeres tend to move nearer to the nuclear periphery
(Salníková et al., 2000; Bártová et al., 2001; Galiová et al.,
2004; Horáková et al., 2010), or relocate more centrally (Bártová
et al., 2008) to the heterochromatin surrounding nucleoli, and
cluster together in chromo-centromeres (Alcobia et al., 2000; Beil
et al., 2002). Movement of the centromeres toward the nuclear
periphery was also observed in early rabbit embryos, once they
had passed the 4-cell stage (Bonnet-Garnier et al., 2018). Such
heterochromatic chromosomal regions may be more likely to be
positioned toward the nuclear periphery which is supported by
the findings of an increased association of chromatin silencing
markers with perinuclear centromeres (Bártová et al., 2008) and
with the under-acetylation of centromeres in both mouse and
human undifferentiated cells (O’Neill and Turner, 1995; Keohane
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et al., 1996). Immaturely developed centromeres, lacking specific
markers of heterochromatin, in embryos and stem cells might be
less able to attach to the mitotic spindle, resulting in aneuploidy.
Indeed, interfering with centromere structure does lead to
mitotic catastrophe in mice (Howman et al., 2000; Artus et al.,
2006).
More recently global genome organization has been
analyzed by a range of chromosome conformation capture
(3C) experiments. Based on forming cross-links between pieces
of chromatin that sit adjacent to each other, fragmenting, ligating
and sequencing the new ligated DNA pieces reveals which parts
of the genome sit together in three-dimensional space within
nuclei. These studies have revealed that the genome is folded
and organized into topologically associated domains (TADs)
which have two sub-types A and B (Lieberman-Aiden et al.,
2009; Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012).
Type A TADs contain active open chromatin whereas B-type
TADs are comprised of inactive more heterochromatic regions
of the genome (Figure 3). These TADs have been found not
only in somatic cells but in ESCs too, revealing similar types
of organization of the genome present before differentiation.
However, in ESCs the number of TADs are increased and the
size is reduced, suggesting that there is in fact a less organized
genome organization (Glinsky et al., 2018). However, closer
study with 3C combined with chromatin factor binding data
reveal that inactive chromatin in PSCs is not organized as would
be expected in somatic cells (de Wit et al., 2013) and there is
noticeably less heterochromatin. Whereas, active regions of the
genome bound by pluripotency factors such as NANOG and
OCT4 bring specific clusters of genes together (de Wit et al.,
2013) to maintain pluripotency. Indeed, at the NANOG locus,
specific proteins interact to regulate NANOG expression being
bound together in an “interactome” containing mediator, a
transcriptional coactivator and a chromosomal architectural
protein with cohesin with the other key players in pluripotency
SOX2, c-MYC, and OCT4 (Apostolou et al., 2013). Others
have shown that OCT4 behaves in a similar way in mouse and
humans iPSC construction (Wei et al., 2013; Zhang et al., 2013).
Phillips-Cremins discusses the differences in ESC nuclei with
respect to gene association with the different TAD sub-types
and how this can switch upon differentiation (Phillips-Cremins,
2014). Indeed, pluripotency genes move from associating with A
TADs to B TADs (Lin et al., 2012). The association of the genome
with the nuclear periphery is also massively altered in mouse
ESCs with genes required to maintain pluripotency away from
the repressive environment of the nuclear edge (Peric-Hupkes
et al., 2010). Figure 3 gives an overview of the differences
between ESCs, iPSCs, and somatic cells, with respect to genome
organization.
It is as yet not clear the effect that aneuploidy could have
on genome organization, with extra genomic regions needing
space at the nuclear envelope or elsewhere. Indeed, although
reports show that extra chromosomes are located in the correct
nuclear compartment in somatic cells, the same is not as clear for
pluripotent cells that lack A-type lamins and have other altered
nuclear architecture. Gene expression can be changed on a large
scale when there are extra chromosomes, and this could be a
more important issue than more simply having extra copies of
some genes. Thus, the real impact of extra chromosomes on
genome organization into TADs and indeed lamina-associated
domains (LADs, see below) and genome function as a whole
remains to be elucidated.
Nuclear Architecture and Sub-Components
The nuclear lamina is located at the nuclear envelope and is
comprised of A and B–type lamins, combined with a plethora
of nuclear envelope transmembrane proteins (Czapiewski et al.,
2016) with many of these proteins having chromatin binding
abilities. Indeed, the nuclear lamins are chromatin-binder and
anchoring specific regions of the genome through LADs (van
Steensel and Belmont, 2017). LADs are regions of the genome
that on the whole are comprised of heterochromatin and
repressed sequences. This is not the case for genes that are
more proximal to nuclear pore complexes that can be active.
In mouse and human iPSCs, LADs have a higher mutation
rate than in non-LADs which could be due to oxidative stress
generated during the reprogramming process (Yoshihara et al.,
2017) (Figure 3).
In human and mouse ES cells, the presence of lamins B1
and B2 was observed with lamin A/C absent (Constantinescu
et al., 2006). Removal of lamin B1 in murine ESCs appeared
in one study to be essential for heterochromatin to be located
at the nuclear periphery (Zheng et al., 2015) but in another
study, the lack of all nuclear lamins, both A-type and B-type
did not have any effect on genome organization and LAD
positioning, implying that other proteins are responsible for
the positioning and anchorage of chromatin through LADs
at the nuclear envelope, for example the integral membrane
protein emerin (Amendola and van Steensel, 2014). In another
study, Robson et al. demonstrated how nuclear envelope
transmembrane proteins NET39, TMEM38A, and WFS1 anchor
myogenic specific genes to the nuclear periphery for repression
in stem cells prior to differentiation (Robson et al., 2016). Despite
some studies (Eckersley-Maslin et al., 2013), the A-type lamins
do not appear to be expressed or required by undifferentiated
embryonic stem cells (Rober et al., 1989; Smith et al., 2017) and
also have been observed to completely disappear with successful
reprogramming of iPSCs (Mattout et al., 2011; Zuo et al., 2012).
Indeed, it seems that A-type lamin upregulation is concomitant
with or even responsible for the start of lineage commitment.
The incorporation of A-type lamins and emerin into the nuclear
lamina induces size and morphology changes in nuclei (Butler
et al., 2009), and correspondingly, nuclei lacking A-type lamins
and emerin fail to change their morphology, with compromised
ability to undergo endoderm differentiation, along with changes
in gene expression (Smith et al., 2017). A-type lamins were
also found to accumulate with the downregulation of OCT4, a
hallmark of differentiation. The absence of lamins A/C has been
suggested to contribute to the ESC nuclei plasticity compared to
the more rigid state of somatic cell nuclei, with hESC lacking
heterochromatin at the nuclear periphery (Smith et al., 2017)
and a global remodeling of the genome organization during
lineage commitment (Peric-Hupkes and van Steensel, 2010).
Mutations in the lamin A gene, LMNA, that cause muscular
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FIGURE 3 | Differences in Genome Organization and Nuclear Architecture between Somatic and Pluripotent Cells. This cartoon displays a cell with two halves. The
darker left hand side represents genome organization and nuclear architecture in a somatic cell and the right hand half is a pluripotent cell. The nuclear lamina
subjacent to the nuclear membrane represents a mixture of A (purple) and B-type (red) lamins, whereas in the PSC there are only B-type lamins. The PML bodies
(green) have a different shape and position in the somatic cells compared to the PSC; in the somatic cell they are spherical and found throughout the nucleoplasm,
whereas in the PSC they are elongated rods in shape and are found more toward the nuclear edge. Concerning the genome, there are both LADs and TADs, with
LADs looking very similar between the somatic and pluripotent cells, whereas there are more TADs of a smaller size in PSC compared to the somatic cell. Pluripotency
genes are active (orange) and found in A-type TADs in PSCs but are inactivated and found in B-type TADs in somatic cells. Lineage specific genes (pink) are
shut-down in PSCs but activated in somatic cells, with association with B TADs and A TADs, respectively. Centromeres (yellow) are more peripheral in somatic cells
whereas in PSCs they can be found more internally.
dystrophy, interfered with the formation of typical LADs at the
nuclear envelope, altering their heterochromatic status which
as a consequence changed the repression of the SOX2 locus,
allowing them to be upregulated (Perovanovic et al., 2016).
Lamin A knockdown affects the SRF pathway that promotes
expression of abundant actin-myosin cytoskeletal components
involved in the differentiation of cells (Swift and Discher, 2014).
The SRF pathway is partially regulated by nuclear actin (Olson
and Nordheim, 2010; Baarlink et al., 2013), which binds to
lamin A (Simon et al., 2010) and other proteins associated with
lamin A, such as emerin. This would suggest a functional role of
lamin A in the indirect regulation of the differentiation of cells
via an inhibitory effect on nuclear actin and myosins. Nuclear
actin and myosin have been shown to work in concert to move
regions of the genome around nuclei (Fedorova and Zink, 2008;
Mehta et al., 2010; Bridger and Mehta, 2011; Kulashreshtha
et al., 2016), but they are also involved in gene expression and
processing. With the significant changes at the nuclear lamina
between the pluripotent state and the somatic/lineage situation
it seems unlikely that there are not changes with respect to LADs
associating with the nuclear lamina, even though they have not
been revealed. Indeed, LADs can also be internally located near
A-type lamins (Briand et al., 2018) and so genome organization
would be expected to change substantially after the A-type lamins
arrive (Figure 3).
Promyelocytic Leukemia Bodies
There exists an emerging role for promyelocytic myeloid (PML)
bodies in stem cell pluripotency and reprogramming, with their
presence required to maintain pluripotency and reprogramming
of cells to iPSCs (Hadjimichael et al., 2017). Some regard PML
bodies in hESCs as comparable structures to those in somatic
cells (Wiblin et al., 2005; Meshorer and Misteli, 2006), with their
spherical unmistakeable morphology. Alternatively, one study
argues that PML bodies in stem cells and somatic cells are long
linear structures or “rods and rosettes” in the embryonic stem
cell nuclei. The study suggested that the unique PML bodies
appear in the early stages of the cell life before any epigenetic
imprinting may occur. Unlike in somatic cells, the PML bodies
would often associate with the nuclear edge and appear less
frequently, independent of different cell line, feeder/matrix,
passaging method and the stage of cell-cycle (Butler et al., 2009).
Additionally, the “rods and rosettes” were often found to appear
near the edge of the undifferentiated ESC colonies. Additionally,
Lawrence and colleagues (Butler et al., 2009) found that the
composition of the PML bodies is different to that found in
somatic cells. hESC PML bodies were found to not contain
SUMO, SP100, or DAXX, which are usually present in those of
somatic cells. These findings have been supported by Tokunaga
et al. (2014), who have also found similar “rod” structures in
their reprogrammed iPSCs. Additionally, it was suggested that
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the round “rosettes” found in their reprogrammed cells that failed
to produce successful iPSCs was a sign of a transitional stage
from somatic cell to iPSC (Tokunaga et al., 2014). Salsman et al.
revealed PML body loss upon differentiation ofmyoblasts and the
relocation of DAXX protein (Salsman et al., 2017) (Figure 3).
The question concerning the differences in genome
organization in ESCs and iPSCs is whether it is important
to assess with respect to risk in a whole organism? It seems
that genome organization is more dis-organized and plastic
and possibly more random. But whether this is detrimental is
debatable since there is evidence that once cells have initiated
their lineage journey these aspects are corrected. However, there
may be more genome instability evident and the consequences
that follow such a situation i.e., chromosomal aberrations. This
may be the downside of maintaining a plastic open genome and
the question as to whether an adult, possibly of advanced age,
has the same capacity to tolerate genomically compromised cells
remains.
Epigenetic Modifications in Pluripotent
Cells
How exactly specific chromatin conformation in ESC nuclei
influences differentiation is unknown, however there has to be a
certain openness of the chromatin (Meshorer and Misteli, 2006),
with markers such as H3K4me3 (Harikumar and Meshorer,
2015). Presumably, this flexibility permits a normal global
gene activity in the cells, whilst cells remain pluripotent and
maintain their self-renewal capacity. This theory is supported
by findings of an increased accumulation of heterochromatin
upon differentiation (Francastel et al., 2000), implying that with a
reduced need of certain genes in specific cell types, transcription
can be silenced (Jiménez et al., 1992; Hu et al., 1997). The
chromatin state of terminally differentiated cell types is more
“rigid,” in comparison to cells with differentiation capability
(Meshorer et al., 2006). This would be an efficient way to
establish tissue-specific gene expression and has been found
to be true for the differentiation of mammalian hemopoetic
cells and in Caenorhabditis elegans; with more terminally
differentiated cells having more heterochromatin accumulation
(Reviewed in Francastel et al., 2000). Indeed, differentiation-
dependent chromatin modifications are observed with an
increase of silencing chromatin markers, such as H3K9me3 and
global cytosine methylation (Lee et al., 2004; Meshorer et al.,
2006), decreased active chromatin markers, such as H3K4me3
(Guenther et al., 2010) and increased H4 deacetylation in
centromere heterochromatin as cells differentiate (O’Neill and
Turner, 1995; Keohane et al., 1996). Interestingly, in hESCs many
genes show both chromatin marks; for repression H3K27me3
and for expression H3K27ac and H3K4me3, indicating genes
are poised ready for expression once differentiation is initiated
(Harikumar and Meshorer, 2015; Theunissen and Jaenisch, 2017;
Godini and Fallahi, 2018). More specifically in ESCs, genes have
the active chromatin mark at their promoters and the repressive
chromatinmarks within the body of the gene, known as bivalency
(Harikumar and Meshorer, 2015). These genes seem to fall into
the category of genes that are required for future development of
the embryo and differentiation. This bivalency was revealed using
chromatin immunoprecipitation ChIP (Bernstein et al., 2006).
Although, the epigenome of any cell can be altered by the
cell itself and by various drugs applied through the medium,
it remains that ATP-chromatin modeling, histone modification
and DNA methylation are critical in tightly regulating the
journey of a stem cell, whether it be embryonic, an induced
pluripotent or otherwise. Interestingly, a stem cell may have a
different epigenetic code to its parent cell, allowing them to be
flexible in becoming which ever lineage they are signaled to
become. In iPSCs reprogramming with the transcription factors
(OCT4, SOX2, KLF4, and c-MYC) leads to the resetting of the
epigenome (Papp and Plath, 2011), with DNA demethylation
leading to the active transcription of pluripotency genes (He et al.,
2017). There is concern and evidence that there is an epigenetic
memory in iPSCs that could remain in the genomes (Papp and
Plath, 2011; Godini and Fallahi, 2018), with the possibility that
this leads to instability later in their differentiation journeys.
Indeed, in low methylated regions this epigenetic memory
lasts for many passages. Whereas, in hypomethylated and
hypermethylated genomic memories are located at conserved
sites for active gene expression (Luu et al., 2018). With respect
to DNA cytosine methylation in preimplantation embryos, DNA
is hypomethylated, allowing for a poised/active gene state,
with a global remethylation commencing at implantation (Guo
et al., 2014; Okae et al., 2014). Indeed, DNA methylation is
critical in cell fate, being directly involved in gene expression in
pluripotency (Singer et al., 2014).
Studies have been performed to compare the epigenetic
landscape of iPSCs with ESCs, to determine their similarity.
Indeed, there are a number of differences (Bilic and Belmonte,
2012). These differences may be due to variations within
populations since when ESCs and iPSCs were derived from
the same origin there were no differences (Mallon et al.,
2014). Thus, it could be argued that to be of clinical use
iPSCs should be screened for specific histone marks and DNA
methylation status of a selected panel of genes prior to being
used.
CURRENT METHODS FOR ANEUPLOIDY
DETECTION
Preimplantation genetic screening is commonly performed on
human IVF embryos for an increased likelihood of a healthy
birth (Munné et al., 1995), as it has been estimated that over 70%
of normally developing human preimplantation embryos have
chromosomal abnormalities (van Echten-Arends et al., 2011;
Mertzanidou et al., 2013). As previously mentioned, the effects
of low-level of aneuploidies in hPSCs are unknown and pose a
serious threat to their therapeutic use because of their growth
advantage in culture and tumorigenic potential, therefore is vital
that they are well-characterized before use. For hPSCs to become
a future treatment option for patients, especially for cell and
gene therapies with a short shelf life, fast and robust methods
for the sensitive detection of chromosomal abnormalities must
be used. Currently, a number of different methods are available
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TABLE 2 | Current methods used for aneuploidy detection and their individual
sensitivities.
Method Sensitivity of aneuploidy detection
qPCR 10% (D’Hulst et al., 2013)
G-Banding 5–10% (Baker et al., 2007)
FISH 1–5% (Downie et al., 1997; Baker et al., 2007)
CGH 10–25% (Lu et al., 2007; Xiang et al., 2008; Manning et al.,
2010; Novik et al., 2014)
dPCR ≤5% (El Khattabi et al., 2016)
NGS <1% (Sachdeva et al., 2017)
for such screening, each with their advantages and disadvantages
with regards to sensitivity, resolution, turnover time, cost and
staff requirement. Commonly used assays to detect chromosomal
abnormalities are listed in Table 2.
The most common method utilized for aneuploidy detection
is G-banding of metaphase chromosome spreads. The traditional
technique that uses a dye to stain and observe specific banding
patterns in condensed chromosomes is highly labor-intensive
and requires trained cytogenetics for analysis. Typically, only
10–30 metaphase spreads are analyzed to assign a karyotype
for the whole population, limiting the sensitivity of such a
method. In addition, this creates difficulty in the detection
of low-level mosaicism in culture; it has been estimated that
only up to 5–10% mosaic aneuploidy detection is possible
using G-banding (Baker et al., 2007) (Table 1), and can often
fail to observe genomic imbalances less than 10 Mbs (Miller
et al., 2010). In addition, G-banding results can be interpreted
differently by different cytogeneticists resulting in inconsistent
outcomes; it is also known for high turnaround times. Despite
these drawbacks, G-banding results in a single-cell analysis, and
examines every chromosome in each cell analyzed, unlike other
cytogenetic-based methods, can detect balanced translocations
and is relatively cost-efficient.
Another common cytogenetic method, fluorescence in-situ
hybridization (FISH), employing a DNA specific probe in
metaphase or interphase cells, also works at the single-cell
level, with the option of multiplexing using different colored
labels for each chromosome (mFISH), which can greatly aid
the interpretation of complex translocations. FISH has been
estimated to be approximately 1 to 5% sensitive for the detection
of specific aneuploidies (Downie et al., 1997; Baker et al., 2007),
can be carried out and analyzed within a few days and is once
again, relatively cost-effective. However, the technique is still
labor-intensive and requires the use of targeted probes for known
abnormalities. FISH, could be successfully utilized as a sensitive
screening method before the therapeutic use of hPSCs if designed
for common aneuploid chromosomes.
The technique of multiplex ligation-dependent probe
amplification (MLPA), originally designed to measure gene-copy
number variations, can also be applied to detect aneuploidies
of specific chromosomes. MLPA is designed to work by the
detection of gene dosage abnormalities by utilizing up to 45
different DNA sequences. Rather than amplify the nucleic
acids in the sample, the technique amplifies the probes that are
added to the sample; the amplification depends on the presence
of specific sequences in the sample. The probe intensities
are quantified and the whole experiment typically takes 2–3
days (Sellner and Taylor, 2004; Shaffer, 2007). While MLPA is
high-throughput and cost-effective, its sensitivity for detection
of mosaicism is unclear, but likely does not exceed 10% (van
Veghel-Plandsoen et al., 2011; Yan et al., 2011) and cannot detect
structural aberrations.
Quantitative PCR (QPCR) may also be employed for the
measurement of gains and losses of specific sequences; multiple
short tandem repeats of the common aneuploidies in live births,
such as trisomy 13, 18, and 21 and the sex chromosome
aneuploidies can be used to amplify the regions of interest.
The method allows the multiplexing of different fluorescence
intensities produced from the PCR, resulting in a fast method for
chromosome copy number detection. Studies have demonstrated
99.2% accuracy for whole chromosome aneuploidy detection
in prenatal diagnosis (Cirigliano et al., 2004; Ogilvie et al.,
2005), however, a level of sensitivity of 10% has been claimed
for aneuploidy detection in mESCs (D’Hulst et al., 2013).
Furthermore, QPCR has been demonstrated to be able to detect
the presence of 20–30% mosaicism (Donaghue et al., 2005) and
has been reported to be a much cheaper and faster alternative
to other assays and many laboratories have now replaced
traditional FISH with QF-PCR (Shaffer, 2007). Unfortunately,
the limitation of QF-PCR is the inability to detect balanced
chromosomal translocations and the assay’s sensitivity is limited
by the measurement of cycle-threshold differences. Digital PCR
(dPCR), a more novel and sensitive technique, employs the
same chemistry and amplification process as QPCR, therefore
its potential for detecting mosaicism and future potential is
much greater (Uchiyama et al., 2016). In the massively parallel
partitioning of single-target molecule PCR reactions, dPCR has
much greater power than QPCR to detect subtle difference
in copy-number. In an analysis of trisomy 21 DNA samples,
mosaicism for chromosome 21 was detected as low as 5%
sensitivity (El Khattabi et al., 2016). With a greater number of
replicate samples and a battery of assays for each chromosome
arm, it is feasible that dPCR could be capable of detecting
genome-wide aneuploidy to a level close to 1%.
Alternatively, chromosomal microarray methods, such
as array-based comparative genomic hybridization (aCGH),
KaryoLite-Bac on Beads R© (KaryoLite BoBs R©) and single-
nucleotide polymorphism techniques can also be used to detect
aneuploidies. DNA microarrays use a panel of DNA sequences
that compare the copy number of each area of interest to a
control to then calculate the gene copy number of the sample
(Shaffer, 2007). The advantage of using a DNA microarray is
the ability to construct the target molecules, although most
commonly the pre-designed, commercially-available microarray
platforms for aCGH are used. The technique can detect
DNA dosage imbalances, such as aneuploidies, deletions and
duplications with a high resolution, dependent on the target of
interest and is a much faster approach than methods, such as
FISH, due to the high-throughput data produced. In addition,
these techniques provide a significantly higher resolution of up
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to 50–500 kbs (Coe et al., 2007; Askree et al., 2013; WiCell, 2017),
but in contrast to FISH and G-banding, the detection sensitivity
of mosaicism is only about 10–25% (Lu et al., 2007; Xiang et al.,
2008; Manning et al., 2010; Novik et al., 2014) but has been
reported to be capable of detecting aneuploidy mosaicism as
low as 5% (Menten et al., 2006), although such high levels of
sensitivity are uncommon.
The evolution of next-generation sequencing (NGS) based
methodologies extends the possible breadth of data which
may be collected on molecular-level changes including at the
single cell level. Whole genome sequencing may allow capture
of the entire DNA sequence, whilst whole exome sequencing
may offer a more affordable approach; both are challenged
by some sequence variables including mononucleotide repeats,
translocations, inversions, and large copy number variations.
Targeted-panels, particularly for cancer-associated variants (such
as those routinely used in cancer diagnostics) may provide
focused data on known-impact genomic changes and also enable,
through a higher number of reads per base pair sequenced,
the detection of sub-clonal mutations down to a level of
∼10% of cells. In a study analysing cells from hundreds of
pre-implantation embryos with whole genome NGS very high
sensitivity and specificity for aneuploidy of all chromosomes was
reached (Sachdev et al., 2017), which could be described as a
detection sensitivity of < 1%. NGS is also useful to assess the
genomic health of PSCs by being employed in RNA-seq and
ChIP-seq (Kidder et al., 2011; Zhang et al., 2013). Interestingly,
RNA-Seq of PSCs with additional chromosomes reveals that
transcription is affected across the whole genome, even for
chromosomes and genes that have a normal copy number (Zhang
et al., 2013). This consequence of aneuploidy is potentially
dramatic if these cells survive in a body.
Additionally, newer karyotyping methods have been
developed to use the changes in global gene expression changes
to monitor chromosomal aberrations (Mayshar et al., 2010;
Weissbein et al., 2016). Such methods could be used be in
the future to determine the cell karyotype, however further
work is required to detect the method’s sensitivity in detecting
chromosomal abnormalities. In addition, testing of different
cell culture conditions would be required, as changes in gene
expression would be detected with changes in the stem cell
growth condition.
A challenge lies, even in the advent of highly sensitive
aneuploidy-detection methods, in determining what confers an
unacceptable level of genomic instability in hPSCs. Much data
may be collected on genomic alterations in in vitro studies, but
until there is a consensus on what safe limits may be, there is a
risk of being overly cautious or hasty in realizing their therapeutic
potential.
CONCLUSION
Chromosomal aneuploidies in hPSCs can impair differentiation
potential (Zhang et al., 2016) and potentially lead to
tumorgenicity (Blum and Benvenisty, 2008; Ben-David and
Benvenisty, 2011), which could limit their future therapeutic
use. Studies on the genomic instability of hPSCs in culture
are ongoing to optimize protocols for best practice. However,
the ability of aneuploid cells to revert to diploid status over
time in culture should not be overlooked, as observed with
trisomy 18 hiPSCs (Li et al., 2017). Furthermore, some studies
have demonstrated that an aberrant karyotype may not affect
the quality of human preimplantation embryos (Mertzanidou
et al., 2013), and indeed using mosaic embryos may still result in
newborns with a normal karyotype (Greco et al., 2015). Although
these studies are encouraging for the employment of embryos
for preimplantation, their use must still be questionable, due
to the possibility of future malignancy (Amariglio et al., 2009)
and findings may not be transferable to using hPSCs in a similar
state.
The high rate of aneuploidies observed in PSCs arises from
a number of possible mechanisms and we have highlighted
impaired mechanisms that affect mitotic segregation of
chromosomes such as DNA damage, lamin B depletion, DNA
damage repair, spindle assembly and checkpoint function. There
are also important differences in the way the genome is organized
and interacted with in interphase nuclei. The epigenome is also
significantly different between PSCs and differentiated cells,
seeming much more “malleable” prior to differentiation. The
impact of aneuploidy on the epigenome is not clear and needs
further exploration.
The prevalence of aneuploidies in PSCs in culture appears
to be driven by the selection of genes which promote survival
during periods of cell stress or offer a growth advantage. To move
forward in the use of embryonic or induced pluripotent stem
cells as therapeutics, methods that can easily be established in
the clinic need should be considered for the high-throughput and
sensitive detection of aneuploidies, such as population and single
cell NGS, Hi-C, ChIP-seq, and RNA-Seq. However, much more
research is required to determine any long-term detrimental
effects using heterogenous stem cell cultures with respect to
genomic content and behavior traits, nuclear architecture and
content, and the epigenome. This will create the knowledge for
the field to agree what constitutes a safe, acceptable limit of
genomic instability in pluripotent cells.
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